Bambuser Q3 2025: Continued Operational Progress and Enterprise Wins Reinforce Foundation for the Next Growth Phase

STOCKHOLM, SE / ACCESS Newswire / October 24, 2025 / Bambuser AB (publ) ("Bambuser")(STO:BUSER)(FRA:5JL) today reports its Q3 2025 results, marking continued progress in operational efficiency and growing traction among global enterprise customers. The company delivered an improved underlying cost structure and further strengthened its position for the next phase of growth. ARR reached SEK […]

CTT Systems AB (publ.) – Interim Report Third Quarter 2025

NYKÖPING, SE / ACCESS Newswire / October 24, 2025 / CTT Systems AB (STO:CTT) THIRD QUARTER 2025 Net sales increased by 29% to MSEK 73.8 (57.4)– Currency adjusted increase of 39% Operating profit (EBIT) increased to MSEK 18.6 (15.0) Operating margin (EBIT margin) amounted to 25% (26) Profit margin amounted to 25% (27) Net profit

Hexagon Interim Report 1 January – 30 September 2025

Third quarter 2025 4% organic revenue growth (using fixed exchange rates and a comparable group structure) — Net sales increased by 0% to 1,303.8 MEUR (1,299.8) — Net sales including the reduction of acquired deferred revenue amounted to 1,303.1 MEUR (1,299.8) — Adjusted gross margin of 66.9% (67.1) — Adjusted operating earnings (EBIT1) decreased by

Nominations Open for American Banker’s Most Innovative People in Finance and Innovation of the Year Awards

New York, United States, Oct. 24, 2025 (GLOBE NEWSWIRE) — Newest ranking program honors the top 50 leaders advancing digital transformation across banking and financial servicesNominations are now open for American Banker's two signature honors that proudly recognize the people and ideas transforming financial services: The Most Innovative People in Finance and Innovation of the

Nominations Open for American Banker’s Most Innovative People in Finance and Innovation of the Year Awards

Nominations Open for American Banker's Most Innovative People in Finance and Innovation of the Year Awards GlobeNewswire October 24, 2025 New York, United States, Oct. 24, 2025 (GLOBE NEWSWIRE) — Newest ranking program honors the top 50 leaders advancing digital transformation across banking and financial servicesNominations are now open for American Banker's two signature honors

TECNO Announces the Winners of the 2025 Shot On CAMON Global Photography Contest — Capturing the Pulse, the Bond, and the Motion of Life

Innovative technology brandTECNO today announced the winners of its 2025 “Shot On CAMON” Global Photography Contest, organized in partnership with Amateur Photographer magazine. Now in its second year, the contest was created to empower creators across emerging markets to capture the world through their own lens and tell authentic human stories powered by cutting-edge technology.

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

(Paris:NANO),(NASDAQ: NBTX), PARIS and CAMBRIDGE, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO — NASDAQ: NBTX – the ''Company''), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced updates to the JNJ-1900 (NBTXR3) clinical development program. Nanobiotix has completed the

Mkango Resources Limited – Confirmation of No Material Change

CALGARY, AB / ACCESS Newswire / October 24, 2025 / At the request of CIRO, Mkango Resources Ltd. (AIM:MKA)(TSX-V:MKA) ("Mkango" or the "Company") wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity. About Mkango Resources Ltd. Mkango

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control

NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control GlobeNewswire October 24, 2025 PARIS and CAMBRIDGE, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO — NASDAQ: NBTX – the ''Company''), a late-stage clinical biotechnology company pioneering physics-based approaches to

Munters Group AB: Strong performance driven by growth in key industries

Divestment of the FoodTech Equipment offering has been completed. The comments and figures in this report refer to continuing operations unless otherwise stated. For more information see pages 16-17. July – September — Order intake increased +57%, driven by strong demand in both Data Center Technologies (DCT) and FoodTech as well as growth in AirTech.

Scroll to Top